Insider · CIK 0001983476

Dambkowski Carl

Reports to the SEC for 2 companies · SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001983476

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-03	APGEApogee Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−111K sh	—	—	0
2026-09-03	APGEApogee Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−125K sh	—	—	0
2026-09-03	APGEApogee Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−83.7K sh	—	—	0
2026-09-03	APGEApogee Therapeutics, Inc.D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−167K sh	—	—	0
2026-09-02	APGEApogee Therapeutics, Inc.D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−1,375 sh	$135.06	−$186K	167,123
2026-08-05	APGEApogee Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+4,125 sh	$22.86	+$94.3K	173,998
2026-08-05	APGEApogee Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−5,500 sh	$134.17	−$738K	168,498
2026-08-05	APGEApogee Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−4,125 sh	—	—	110,665
2026-07-14	APGEApogee Therapeutics, Inc.G Gift	Chief Medical Officer	GGift	−8,000 sh	—	—	169,873
2026-07-01	APGEApogee Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−4,125 sh	—	—	114,790
2026-07-01	APGEApogee Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+4,125 sh	$22.86	+$94.3K	183,373
2026-07-01	APGEApogee Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−5,500 sh	$132.74	−$730K	177,873
2026-06-22	APGEApogee Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−26.4K sh	$132.60	−$3.5M	179,248
2026-06-12	ORKAOruka Therapeutics, Inc.S Sale	Director	SSale	−12.6K sh	$70.11	−$882K	38,743
2026-06-11	ORKAOruka Therapeutics, Inc.S Sale	Director	SSale	−22.4K sh	$70.13	−$1.57M	51,326
2026-06-03	APGEApogee Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−4,125 sh	—	—	118,915
2026-06-03	APGEApogee Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−5,500 sh	$78.71	−$433K	205,648
2026-06-03	APGEApogee Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+4,125 sh	$22.86	+$94.3K	211,148
2026-06-02	ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+9,136 sh	—	—	9,136
2026-05-21	ORKAOruka Therapeutics, Inc. · Warrant (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−11.9K sh	—	—	10,952
2026-05-21	ORKAOruka Therapeutics, Inc.S Sale	Director	SSale	−13.2K sh	$59.97	−$794K	73,743
2026-05-21	ORKAOruka Therapeutics, Inc.S Sale	Director	SSale	−53.4K sh	$59.10	−$3.16M	86,978
2026-05-21	ORKAOruka Therapeutics, Inc.S Sale	Director	SSale	−38.3K sh	$58.43	−$2.24M	140,425
2026-05-21	ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−38.7K sh	—	—	32,737
2026-05-21	ORKAOruka Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+11.7K sh	$11.77	+$137K	178,743
2026-05-21	ORKAOruka Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+11.9K sh	$7.80	+$92.9K	167,076
2026-05-21	ORKAOruka Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+38.7K sh	$6.84	+$265K	155,172
2026-05-21	ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−11.7K sh	—	—	5,833
2026-05-06	APGEApogee Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,800 sh	$84.60	−$152K	207,023
2026-05-06	APGEApogee Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−3,700 sh	$83.92	−$311K	208,823
2026-05-06	APGEApogee Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+4,125 sh	$22.86	+$94.3K	212,523
2026-05-06	APGEApogee Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−4,125 sh	—	—	123,040
2026-04-01	APGEApogee Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−4,125 sh	—	—	127,165
2026-04-01	APGEApogee Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−100 sh	$85.89	−$8,589	208,398
2026-04-01	APGEApogee Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−2,702 sh	$85.33	−$231K	208,498
2026-04-01	APGEApogee Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−2,698 sh	$84.31	−$227K	211,200
2026-04-01	APGEApogee Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+4,125 sh	$22.86	+$94.3K	213,898
2026-03-04	APGEApogee Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−3,225 sh	$70.33	−$227K	212,048
2026-03-04	APGEApogee Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+4,125 sh	$22.86	+$94.3K	215,273
2026-03-04	APGEApogee Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−4,125 sh	—	—	131,290
2026-03-04	APGEApogee Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−200 sh	$73.26	−$14.7K	209,773
2026-03-04	APGEApogee Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−2,075 sh	$71.98	−$149K	209,973
2026-02-04	APGEApogee Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,299 sh	$66.85	−$86.8K	211,448
2026-02-04	APGEApogee Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−100 sh	$67.88	−$6,788	211,348
2026-02-04	APGEApogee Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−2,481 sh	$64.88	−$161K	214,167
2026-02-04	APGEApogee Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,420 sh	$65.83	−$93.5K	212,747
2026-02-04	APGEApogee Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−200 sh	$68.94	−$13.8K	211,148
2026-02-04	APGEApogee Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+4,125 sh	$22.86	+$94.3K	216,648
2026-02-04	APGEApogee Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−4,125 sh	—	—	135,415
2026-01-23	ORKAOruka Therapeutics, Inc.J Other	Director	JOther	+116K sh	—	—	116,483

Recent filings

Accepted (ET)
Sep 34
Dambkowski Carl0001140361-26-035613
SEC(opens sec.gov)
Aug 74
Dambkowski Carl0001104659-26-092838
SEC(opens sec.gov)
Jul 164
Dambkowski Carl0001104659-26-084344
SEC(opens sec.gov)
Jul 24
Dambkowski Carl0001104659-26-080477
SEC(opens sec.gov)
Jun 244
Dambkowski Carl0001104659-26-077427
SEC(opens sec.gov)
Jun 124
Dambkowski Carl0000907654-26-000054
SEC(opens sec.gov)
Jun 54
Dambkowski Carl0001104659-26-071076
SEC(opens sec.gov)
Jun 34
Dambkowski Carl0000907654-26-000052
SEC(opens sec.gov)
May 224
Dambkowski Carl0000907654-26-000043
SEC(opens sec.gov)

Companies

Address

C/O APOGEE THERAPEUTICS, INC. 1 LETTERMAN DRIVE, BUILDING B

SAN FRANCISCO, CA, 94129